Last reviewed · How we verify

NCT05074069

A Review of Functional and Surgical Outcomes of Gynaecological Reconstruction in the Context of Pelvic Exenteration

Completed Last updated 31 March 2023
What this trial tests

trial testing Gynaecological reconstruction in Pelvic Cancer in 334 participants. Completed in 1 September 2022.

Timeline
1 July 2021
Primary endpoint
1 July 2022
1 September 2022

Quick facts

Lead sponsorSt Vincent's University Hospital, Ireland
StatusCompleted
Study typeOBSERVATIONAL
Enrollment334
Start date1 July 2021
Primary completion1 July 2022
Estimated completion1 September 2022
Sites1 location across Ireland

Drugs / interventions tested

Conditions studied

Sponsor

St Vincent's University Hospital, Ireland

Who can join

18 and older, female only, with Pelvic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with locally advanced pelvic malignancy undergo radical procedures, necessitate organ reconstruction. Little is known about the preferred methods of gynaecological organ reconstruction in the context of pelvic exenteration. This review aims to identify which methods are commonly used and what outcomes are associated with each technique in order to further guide future practice.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A review of functional and surgical outcomes of gynaecological reconstruction in the context of pelvic exenteration.
    PelvEx Collaborative. · · 2024 · cited 2× · PMID 38096764 · DOI 10.1016/j.suronc.2023.101996

Verify or expand the search:

Other recruiting trials for Pelvic Cancer

Currently open trials in the same condition.

Other St Vincent's University Hospital, Ireland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05074069.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing